phosphoserine has been researched along with Nerve Degeneration in 13 studies
Phosphoserine: The phosphoric acid ester of serine.
Nerve Degeneration: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In vivo, a middle cerebral artery occlusion/reperfusion (MCAO/R) model in adult male Sprague Dawley rats (250-300 g) was established, and in vitro, cultured primary neurons were subjected to oxygen-glucose deprivation/reoxygenation (OGD/R) to imitate I/R injury." | 1.62 | Phosphorylation at S548 as a Functional Switch of Sterile Alpha and TIR Motif-Containing 1 in Cerebral Ischemia/Reperfusion Injury in Rats. ( Chen, G; Li, H; Li, X; Shen, H; Sun, Q; Wang, Z; Wu, J; Wu, X; Xue, T; Zhang, Y, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Xue, T | 1 |
| Sun, Q | 1 |
| Zhang, Y | 1 |
| Wu, X | 1 |
| Shen, H | 1 |
| Li, X | 1 |
| Wu, J | 1 |
| Li, H | 1 |
| Wang, Z | 1 |
| Chen, G | 1 |
| Zhang, S | 1 |
| Liu, YQ | 1 |
| Jia, C | 1 |
| Lim, YJ | 1 |
| Feng, G | 1 |
| Xu, E | 1 |
| Long, H | 1 |
| Kimura, Y | 1 |
| Tao, Y | 1 |
| Zhao, C | 1 |
| Wang, C | 1 |
| Liu, Z | 2 |
| Hu, JJ | 1 |
| Ma, MR | 1 |
| Jiang, L | 1 |
| Li, D | 1 |
| Wang, R | 1 |
| Dawson, VL | 1 |
| Dawson, TM | 1 |
| Li, YM | 1 |
| Mao, X | 1 |
| Liu, C | 1 |
| Van Rompuy, AS | 1 |
| Oliveras-Salvá, M | 1 |
| Van der Perren, A | 1 |
| Corti, O | 1 |
| Van den Haute, C | 1 |
| Baekelandt, V | 1 |
| Zhuang, N | 1 |
| Li, L | 1 |
| Chen, S | 1 |
| Wang, T | 1 |
| Mukerjee, R | 1 |
| Deshmane, SL | 1 |
| Fan, S | 1 |
| Del Valle, L | 1 |
| White, MK | 1 |
| Khalili, K | 1 |
| Amini, S | 1 |
| Sawaya, BE | 1 |
| Iijima-Ando, K | 2 |
| Zhao, L | 1 |
| Gatt, A | 2 |
| Shenton, C | 1 |
| Iijima, K | 2 |
| Ksiezak-Reding, H | 1 |
| Pyo, HK | 1 |
| Feinstein, B | 1 |
| Pasinetti, GM | 1 |
| Klumpp, S | 1 |
| Thissen, MC | 1 |
| Krieglstein, J | 1 |
| Copani, A | 1 |
| Bruno, V | 1 |
| Battaglia, G | 1 |
| Leanza, G | 1 |
| Pellitteri, R | 1 |
| Russo, A | 1 |
| Stanzani, S | 1 |
| Nicoletti, F | 1 |
| Price, MT | 1 |
| Romano, C | 1 |
| Fix, AS | 1 |
| Tizzano, JP | 1 |
| Olney, JW | 1 |
| Shiurba, RA | 1 |
| Ishiguro, K | 1 |
| Takahashi, M | 1 |
| Sato, K | 1 |
| Spooner, ET | 1 |
| Mercken, M | 1 |
| Yoshida, R | 1 |
| Wheelock, TR | 1 |
| Yanagawa, H | 1 |
| Imahori, K | 1 |
| Nixon, RA | 1 |
| Oh, JD | 1 |
| Vaughan, CL | 1 |
| Chase, TN | 1 |
1 review available for phosphoserine and Nerve Degeneration
| Article | Year |
|---|---|
Protein phosphatases types 2Calpha and 2Cbeta in apoptosis.
Topics: Animals; Apoptosis; Cell Survival; Enzyme Activation; Fatty Acids, Nonesterified; Fatty Acids, Unsat | 2006 |
12 other studies available for phosphoserine and Nerve Degeneration
| Article | Year |
|---|---|
Phosphorylation at S548 as a Functional Switch of Sterile Alpha and TIR Motif-Containing 1 in Cerebral Ischemia/Reperfusion Injury in Rats.
Topics: Animals; Armadillo Domain Proteins; Axons; Brain Ischemia; Cells, Cultured; Cytoskeletal Proteins; I | 2021 |
Mechanistic basis for receptor-mediated pathological α-synuclein fibril cell-to-cell transmission in Parkinson's disease.
Topics: alpha-Synuclein; Amyloid; Amyloid beta-Protein Precursor; Animals; Antigens, CD; Cell Line, Tumor; E | 2021 |
Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration.
Topics: alpha-Synuclein; Animals; Cell Count; Cell Line, Tumor; Dependovirus; Dopaminergic Neurons; Female; | 2015 |
PINK1-dependent phosphorylation of PINK1 and Parkin is essential for mitochondrial quality control.
Topics: Amino Acid Sequence; Animals; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; | 2016 |
Involvement of the p53 and p73 transcription factors in neuroAIDS.
Topics: AIDS Dementia Complex; Apoptosis; Apoptosis Regulatory Proteins; Brain; Cell Line, Tumor; DNA-Bindin | 2008 |
A DNA damage-activated checkpoint kinase phosphorylates tau and enhances tau-induced neurodegeneration.
Topics: Animals; Checkpoint Kinase 1; Checkpoint Kinase 2; DNA Damage; Drosophila melanogaster; Enzyme Activ | 2010 |
Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Brain; Checkpoint | 2010 |
Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro.
Topics: Alzheimer Disease; Amino Acid Sequence; Biomarkers; Cloning, Molecular; Consensus Sequence; Escheric | 2003 |
Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide.
Topics: Aminobutyrates; Amyloid beta-Peptides; Animals; Apoptosis; Benzoates; Calcium Channels; Cells, Cultu | 1995 |
Blockade of the second messenger functions of the glutamate metabotropic receptor is associated with degenerative changes in the retina and brain of immature rodents.
Topics: Alanine; Animals; Animals, Newborn; Asparagine; Brain Diseases; Excitatory Amino Acid Antagonists; I | 1995 |
Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amino Acid Sequence; Antibody Specificity; Brain; | 1996 |
Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antibodies; Antiparkinson Agent | 1999 |